Company Description
CeriBell is a commercial-stage medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions.
We have developed the Ceribell System, a novel, point-of-care electroencephalography platform specifically designed to address the unmet needs of patients in the acute care setting.
By combining proprietary, highly portable, and rapidly deployable hardware with sophisticated artificial intelligence-powered algorithms, the Ceribell System enables rapid diagnosis and continuous monitoring of patients with neurological conditions.
We are initially focused on becoming the standard of care for the detection and management of seizures in the acute care setting.
The Ceribell System has been adopted by more than 450 active accounts, ranging from top academic centers to small community hospitals, and has been used to care for over 100,000 patients.
| Country | United States |
| Founded | 2014 |
| IPO Date | Oct 11, 2024 |
| Industry | Medical Devices |
| Sector | Healthcare |
| Employees | 229 |
| CEO | Jane Chao, Ph.D. |
Contact Details
Address: 360 N. Pastoria Avenue Sunnyvale, CA 94085 United States | |
| Phone | (800) 436-0826 |
| Website | ceribell.com |
Stock Details
| Ticker Symbol | CBLL |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| IPO Price | $17.00 |
| CIK Code | 0001861107 |
| Employer ID | 47-1785452 |
| SIC Code | 3845 |
Key Executives
| Name | Position |
|---|---|
| Xingjuan (Jane) Chao, Ph.D. | President, Chief Executive Officer, Co-Founder, and Director |
| Scott Blumberg | Chief Financial Officer |
| Joshua Copp | Chief Business Officer |
| Raymond Woo, Ph.D. | Chief Technology Officer |
| Rebecca (Beckie) Robertson | Chair |
| Juliet Tammenoms Bakker | Director |
| William W. Burke | Director |
| Lucian Iancovici, M.D. | Director |
| Josef Parvizi, M.D., Ph.D. | Director, Co-Founder and Chief Medical Advisor |
| Joseph M. Taylor | Director |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Oct 15, 2024 | 8-K | Current Report |
| Oct 11, 2024 | 424B4 | Prospectus |
| Oct 11, 2024 | S-8 | Securities to be offered to employees in employee benefit plans |
| Oct 10, 2024 | EFFECT | Notice of Effectiveness |
| Oct 10, 2024 | CERT | Certification by an exchange approving securities for listing |
| Oct 9, 2024 | FWP | Free Writing Prospectus |
| Oct 9, 2024 | S-1/A | [Amend] General form for registration of securities under the Securities Act of 1933 |
| Oct 8, 2024 | 8-A12B | Registration of securities |
| Oct 7, 2024 | S-1/A | [Amend] General form for registration of securities under the Securities Act of 1933 |
| Sep 19, 2024 | S-1/A | [Amend] General form for registration of securities under the Securities Act of 1933 |